Evolving Clinical Evidence on Fenbendazole in Oncology (2025–2026)
Introduction Fenbendazole has become one of the most discussed repurposed benzimidazoles in the metabolic oncology space. The interest is not driven by definitive clinical proof, but by three consistent realities:…